Therapeutic angiogenesis

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine

Background:

• Coronary artery disease (CAD) is a leading cause of death globally.
• Current treatments include risk factor modification, medical therapy, and revascularization procedures like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
• A subset of patients with complex CAD are not candidates for conventional revascularization.

Purpose of the Study:

• To introduce therapeutic angiogenesis as a novel treatment strategy.
• To address the unmet need for treating patients with diffuse or complex coronary artery disease unsuitable for standard revascularization.
• To highlight the potential of therapeutic angiogenesis in improving myocardial blood supply and alleviating symptoms.

Main Methods:

• Review of current treatment approaches for coronary artery disease.
• Analysis of patient populations unsuitable for PCI or CABG.
• Introduction of therapeutic angiogenesis as an emerging medical technology.

Main Results:

• Approximately 12% of patients in a tertiary referral center analysis were unsuitable for revascularization.
• The number of patients ineligible for revascularization is projected to increase.
• Therapeutic angiogenesis presents a potential solution for this growing patient group.

Conclusions:

• Therapeutic angiogenesis offers a promising new avenue for treating ischemic heart disease.
• This approach aims to improve blood flow to the heart muscle in patients with limited treatment options.
• It holds potential for symptomatic relief in a significant and expanding patient population.